Prolonged chemotherapeutic remission and possible cure of metastatic dysgerminoma

The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

Alimentary pharmacology & therapeutics·2015

HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells.

The Journal of experimental medicine·2001

HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.

Immunity·2001

Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status.

Journal of virology·2001

Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.

Journal of virology·2001

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.

Cell·2001

Molecular biomarkers in uterine sarcomas: a review of reviews with genomic data integration.

Gynecologic oncology·2026

Farletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study.

Gynecologic oncology·2026

Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort.

Gynecologic oncology·2026

Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.

Gynecologic oncology·2026

Immunotherapy-induced thyroid dysfunction and diabetes mellitus in gynecologic oncology patients: a retrospective cohort study.

Gynecologic oncology·2026

The diagnostic value of serum glucagon-like peptide-1 (GLP-1) levels in endometrial cancer among obese women.

Gynecologic oncology·2026

From Phase Ib/II to Seamless Phase II/III: A Simulation-Based Discussion of Design Strategies for Dose Optimization and Confirmatory Phase.

Clinical pharmacology and therapeutics·2026

INSR Armoring Protects CAR-NK and CAR-T Cells Against Tumor Stroma-Induced CAR Shedding by Maintaining Cholesterol Homeostasis.

Cancer research·2026

Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies.

Journal of comparative effectiveness research·2026

Epidemiology of medication-related problems and antimicrobial utilisation among critically ill cancer patients: Determinants, pharmacist interventions and clinical outcomes-A prospective observational study.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Enhancing Cancer Immunotherapy with Berberine and Its Loaded Nanoparticles: A Systematic Review.

Anti-cancer agents in medicinal chemistry·2026

Magnetic and Non-Magnetic Halloysite Nanotubes Functionalized with Folic Acid for the Targeted Delivery of [Pd(dipic)Cl].H2O: Cytotoxicity and Apoptosis Induction in Colon Cancer Cells.

Anti-cancer agents in medicinal chemistry·2026

Related Experiment Videos

Prolonged chemotherapeutic remission and possible cure of metastatic dysgerminoma

Related Concept Videos

The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells.

HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.

Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status.

Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.

Molecular biomarkers in uterine sarcomas: a review of reviews with genomic data integration.

Farletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study.

Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort.

Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.

Immunotherapy-induced thyroid dysfunction and diabetes mellitus in gynecologic oncology patients: a retrospective cohort study.

The diagnostic value of serum glucagon-like peptide-1 (GLP-1) levels in endometrial cancer among obese women.

From Phase Ib/II to Seamless Phase II/III: A Simulation-Based Discussion of Design Strategies for Dose Optimization and Confirmatory Phase.

INSR Armoring Protects CAR-NK and CAR-T Cells Against Tumor Stroma-Induced CAR Shedding by Maintaining Cholesterol Homeostasis.

Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies.

Epidemiology of medication-related problems and antimicrobial utilisation among critically ill cancer patients: Determinants, pharmacist interventions and clinical outcomes-A prospective observational study.

Enhancing Cancer Immunotherapy with Berberine and Its Loaded Nanoparticles: A Systematic Review.

Magnetic and Non-Magnetic Halloysite Nanotubes Functionalized with Folic Acid for the Targeted Delivery of [Pd(dipic)Cl].H2O: Cytotoxicity and Apoptosis Induction in Colon Cancer Cells.

Related Experiment Videos

Prolonged chemotherapeutic remission and possible cure of metastatic dysgerminoma

Related Concept Videos

Related Articles